About this medicine
Product information is provided to support understanding and conversations with your care team. Follow the approved leaflet and your prescriber’s instructions.
Content migrated from the company website; pending clinical review before final publication.
Dosage forms
Oral tablets, 500 mg
Drug class
Pyrimidine analogues / antimetabolites
Administration
Take daily at consistent times, 12 hours apart. Swallow whole with food, within 30 minutes after a meal.
Uses
• Colorectal cancer in various settings: metastatic disease, stage III after surgery (adjuvant therapy), or before surgery
• Metastatic or advanced breast cancer
• Esophageal and gastric cancer (gastroesophageal cancer)
• Pancreatic cancer (adjuvant therapy)
Competitive advantages
Capecitabine is taken orally, providing greater convenience for patients, reducing the need for hospitalization and improving quality of life. In the body, it is selectively converted to active 5-FU in tumor tissues, resulting in increased effectiveness and fewer systemic adverse effects.
It also allows treatment at home and removes the need for injection equipment or continuous infusion pumps. Easier combination with other oral and injectable medicines is another advantage.
Original company product page ↗